Patent Assignment
Reel/Frame 053413/0327
Assignment of Assignor's Interest
Recorded: 2020-08-05
Pages: 13
Assignors
SANDS, ARTHUR T
Executed: 2020-06-09
BENCE, NEIL F.
Executed: 2020-05-14
ZAPF, CHRISTOPH
Executed: 2020-05-14
COHEN, FREDERICK
Executed: 2020-05-14
WANG, CHENBO
Executed: 2020-05-13
CUMMINS, THOMAS
Executed: 2020-05-25
TANAKA, HIROKO
Executed: 2020-05-13
SHUNATONA, HUNTER
Executed: 2020-05-28
CARDOZO, MARIO
Executed: 2020-05-13
WEISS, DAHLIA
Executed: 2020-05-13
GOSLING, JENNIFA
Executed: 2020-05-20
Assignee
TIZONA THERAPEUTICS
4000 SHORELINE COURT, SUITE 200, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
3-Substituted Piperidine Compounds for Cbl-B Inhibition, and Use of a Cbl-B Inhibitor in Combination with a Cancer Vaccine and/or Oncolytic Virus
PCT:
PCT/US2020/027492 ↗
3-Substituted Piperidine Compounds for Cbl-B Inhibition, and Use Thereof
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 23, 2020
From: SANDS, ARTHUR T.; BENCE, NEIL F.; ZAPF, CHRISTOPH W.; COHEN, FREDERICK
To: NURIX THERAPEUTICS, INC.
Reel/Frame 053569/0709 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 053413 Frame: 0327. Assignor(S) Hereby Confirms the Assignment .
Aug 23, 2020
From: SANDS, ARTHUR T.; BENCE, NEIL F.; ZAPF, CHRISTOPH W.; COHEN, FREDERICK
To: NURIX THERAPEUTICS, INC.
Reel/Frame 053581/0931 →